Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
OPAL logo

The Oxford Pain, Activity and Lifestyle (OPAL) study is now open to recruitment.

The OPAL cohort study, which is part of the BOOST (Better Outcomes for Older people with Spinal Trouble) programme of work, is studying health outcomes in older adults. The pilot site, a GP practice in Birmingham, opened on 4 October 2016 and further sites will be opened shortly.

OPAL is a five year survey study which looks at how people's health and physical activity change over time. Data will be collected from 4,000 community dwelling adults, aged 65 and over, from 40 GP practices across England. The information collected will help the study team to understand how a person's health affects their mobility as they age, and provide insight into improving the management of health in older adults.

The aim is to develop a prognostic tool using the study data that will help older people, GPs and other health professionals identify when low back pain is a risk factor for disability, functional limitation and loss of mobility, and when it should be prioritised as a treatment target.

More information can be found on the study website www.opalstudy.org.uk

Similar stories

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.